Dr Agarwals Eye Hospital Ltd (DRAGARWQ) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Dr Agarwals Eye Hospital Ltd on NSE and BSE, with an AI summary of each filing.
Copy of the communication sent to equity shareholders intimating the fixation of record date is submitted.
Others (Uncategorized) · 27 Oct 2026, 11:51 pm
Dr. Agarwal’s Eye Hospital Fixes Record Date and Swap Ratio for Merger Dr. Agarwal’s Eye Hospital Limited fixed 18th Nov'26 as the record date for its NCLT-sanctioned Scheme of Amalgamation with Dr. Agarwal’s Health Care Limited. Under the approved share exchange ratio, eligible shareholders will receive 23 fully paid-up equity shares (face value ₹1 each) of Dr. Agarwal’s Health Care Limited for every 2 equity shares (face value ₹10 each) held in Dr. Agarwal’s Eye Hospital Limited. Fractional entitlements will be consolidated, allotted to a trustee, and sold on stock exchanges within 90 days of allotment.
Fixation of Record Date w.r.t. the scheme of amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is submitted.
Others · 21 Oct 2026, 1:16 am
Dr. Agarwal’s Eye Hospital Sets Record Date for Merger with Health Care Entity Dr. Agarwal’s Eye Hospital Limited announced that its Scheme of Amalgamation with Dr. Agarwal’s Health Care Limited will become effective on 1st Nov'26, following NCLT sanction and RoC filing, with the Appointed Date being 1st Apr'26. The Board fixed 18th Nov'26 as the Record Date for allotting consideration shares. Eligible shareholders will receive 23 equity shares (FV ₹1) of Dr. Agarwal’s Health Care Limited for every 2 equity shares (FV ₹10) held. Consequently, the transferor company and its Board will dissolve on 1st Nov'26.
Outcome of Board Meeting held on October 20, 2026, in connection with a Material Update on Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care ....
Others (Uncategorized) · 21 Oct 2026, 1:06 am
Dr. Agarwal’s Eye Hospital Finalizes Amalgamation Effective Date and Share Swap Ratio Dr. Agarwal’s Eye Hospital approved the implementation of its scheme of amalgamation with Dr. Agarwal’s Health Care, setting the effective date as 1st Nov'26 with an appointed date of 1st Apr'26 following NCLT approval. The company fixed 18th Nov'26 as the record date for share allotment. Eligible shareholders will receive 23 equity shares (FV ₹1 each) of Dr. Agarwal’s Health Care for every 2 equity shares (FV ₹10 each) held in Dr. Agarwal’s Eye Hospital. The company and its board will dissolve without winding up on 1st Nov'26.
Receipt of sanction from the Honble NCLT, Chennai bench towards the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and its respective ....
Others (Uncategorized) · 06 Oct 2026, 4:21 am
NCLT Approves Amalgamation of Dr. Agarwal’s Eye Hospital into AHCL NCLT Chennai has sanctioned the Scheme of Amalgamation of Dr. Agarwal’s Eye Hospital Limited (AEHL) with and into Dr. Agarwal’s Health Care Limited (AHCL). Pronounced on 30th Sep'26 and uploaded on 5th Oct'26, the merger has an appointed date of 1st Apr'26. The scheme will become operative once all specified conditions are met. AEHL will subsequently announce key execution details, including scheme effectiveness, the record date, and share allotment under the agreed share exchange ratio.
32nd Annual General Meeting (AGM)- Results of the remote e-voting and e-voting during the AGM along with the Scrutinizer report, is submitted.
Annual General Meeting · 10 Sept 2026, 6:46 pm
Summary of proceedings of the 32nd Annual General Meeting of the Company held on September 09, 2026, is submitted.
Annual General Meeting · 09 Sept 2026, 11:51 pm
Media Release - Launch of World''s first Pinhole Pupilloplasty (PPP) Centre by the Company, is submitted.
Press Release · 27 Aug 2026, 9:09 pm
Dr. Agarwal’s Eye Hospital Launches World's First Pinhole Pupilloplasty Centre Dr. Agarwal’s Eye Hospital (Scrip Code: 526783) launched the world's first dedicated Pinhole Pupilloplasty (PPP) Centre at its flagship facility in Chennai on 27 Aug '26. The centre will focus on a proprietary microsurgical technique developed by Dr. Amar Agarwal to treat complex corneal disorders like scars and irregular corneas. This innovative procedure does not require donor corneal tissue, addressing a significant global shortage. The technique has already provided vision to over 5,000 patients and marks a key step in advancing tissue-preserving ophthalmic solutions.
Notice convening the 32nd Annual General Meeting of the members of the Company which is scheduled to be held on September 09, 2026, is submitted.
Annual General Meeting · 15 Aug 2026, 12:15 am
The record date for the payment of final dividend for the financial year 2025-26 is submitted.
Dividend · 15 Aug 2026, 12:12 am
Dr. Agarwal's Proposes FY26 Dividend and Seeks Key Approvals Dr. Agarwal's Eye Hospital has proposed a final dividend of INR 4.00 per share (40%) for FY26, subject to shareholder approval at its 32nd AGM on 09 Sep'26. The record date for the dividend is set for 02 Sep'26, with payment scheduled on or before 08 Oct'26. Additionally, the company seeks approval for a revision in remuneration for Chairman Dr. Amar Agarwal and Whole-Time Director Dr. Athiya Agarwal, effective 01 Apr'26. The agenda also includes the re-appointment of Dr. Adil Agarwal as a director.
Annual Report of Dr. Agarwal's Eye Hospital Limited for the financial year 2025-26 is submitted
Others (Uncategorized) · 15 Aug 2026, 12:08 am
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
Acquisition/ Disposal of Shares · 14 Aug 2026, 4:31 pm
Invesco Mutual Fund Increases Stake in Dr. Agarwal's Healthcare Invesco Mutual Fund acquired 69,38,186 shares of Dr. Agarwal's Healthcare Limited through an open market transaction on Aug 12, '26. This purchase represents 2.1885% of the company's paid-up capital. Following the acquisition, Invesco's total holding increased from 3.0240% to 5.2125% of the total paid-up share capital. The new aggregate holding amounts to 1,65,25,136 shares. The acquisition was made across several Invesco schemes, including its Flexi Cap, Smallcap, and Midcap funds. This transaction breaches the 5% substantial acquisition threshold.
Reappointment of cost auditors to conduct audit of the cost records of the Company for the financial year 2026-27, is submitted.
Change in Management · 03 Aug 2026, 11:06 pm
Dr. Agarwal's Eye Hospital Reports Strong Q1 FY27 Results Dr. Agarwal's Eye Hospital posted strong Q1 FY27 results with revenue from operations at ₹142.97 cr, up 22.3% YoY. Profit After Tax (PAT) grew 35.5% YoY to ₹23.38 cr. EBITDA for the quarter stood at ₹45.22 cr, a 19.2% YoY increase. Basic EPS was ₹48.38, up from ₹36.72 in the prior year's quarter. The Board also re-appointed M/s. B Y & Associates as Cost Auditors for FY27. The results were approved at the board meeting on 03 Aug'26.
Unaudited Financial Results for the quarter ended June 30, 2026, is submitted.
Financial Result · 03 Aug 2026, 11:03 pm
Dr. Agarwal's Reports Strong Q1 FY27 Results with 35% YoY PAT Growth Dr. Agarwal's Eye Hospital reported strong Q1 FY27 results, with revenue from operations reaching ₹142.97 crore, a 22.3% YoY increase. EBITDA grew 19.2% YoY to ₹45.22 crore. Net Profit After Tax (PAT) for the quarter ended Jun'26 stood at ₹23.38 crore, marking a significant 35.5% YoY growth from ₹17.26 crore in the corresponding prior-year period. Basic EPS increased to ₹48.38 from ₹36.72 YoY. The Board also approved the re-appointment of M/s. B Y & Associates as Cost Auditors for FY27.
Outcome of the proceedings of the Board Meeting held on August 03, 2026 is submitted.
Outcome · 03 Aug 2026, 10:54 pm
Dr Agarwals Eye Hospital Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Crore) ■ Revenue: 143 (+22.3% YoY | +19.1% QoQ) ■ EBITDA: 43.3 (+16.5% YoY | +28.3% QoQ) ■ EBITDA Margin (%): 30.3 (-150 bps YoY | +215 bps QoQ) ■ PAT: 23.4 (+35.5% YoY | +44.0% QoQ) ■ EPS (INR): 48.4 (+31.8% YoY | +44.0% QoQ)
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve the unaudited financial ....
Intimation · 03 Aug 2026, 5:30 am
Dr. Agarwal's Eye Hospital Board Meeting for Q1 FY27 Results Dr. Agarwal's Eye Hospital (BSE: 526783) has scheduled a Board of Directors meeting on Mon, 03 Aug'26. The primary agenda is to consider and approve the un-audited financial results for the quarter ended Jun 30, 2026. In line with insider trading regulations, the trading window will remain closed for all designated persons until 48 hours after the financial results are publicly announced. This meeting is a key event for investors tracking the company's Q1 FY27 performance.
Voting results of the Hon''ble NCLT convened meeting of the Unsecured Creditors of Dr. Agarwal''s Eye Hospital Limited is submitted.
Others (Uncategorized) · 03 Jul 2026, 4:29 am
Dr. Agarwal's Unsecured Creditors Approve Amalgamation Scheme Unsecured creditors of Dr. Agarwal's Eye Hospital Ltd approved the Scheme of Amalgamation with Dr. Agarwal's Health Care Ltd at an NCLT-convened meeting on 2nd Jul'26. The resolution was passed with 100% of the total 4,33,87,320 votes cast in favour, meeting the requisite majority requirement. Voting was conducted via remote e-voting and physical polls. This approval marks a key step in the proposed merger between the transferor company (Dr. Agarwal's Eye Hospital) and the transferee company (Dr. Agarwal's Health Care).
Summary of the proceedings of the Hon''ble NCLT convened meeting of the unsecured creditors of Dr. Agarwal''s Eye Hospital Limited is submitted.
Others (Uncategorized) · 03 Jul 2026, 4:26 am
Dr. Agarwal's Unsecured Creditors Meet on Amalgamation Scheme Unsecured creditors of Dr. Agarwal's Eye Hospital Limited met on 02 Jul'26, as directed by the NCLT, to vote on the Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The meeting, chaired by Kanwal Jeet Arora, sought a Special Majority resolution for approval. A total of 31 unsecured creditors attended in person or by proxy, fulfilling the quorum requirement of 30. Voting was conducted through e-voting and polling papers, with results to be consolidated and reported by the Scrutinizer.
Voting results of the Hon''ble NCLT convened meeting of the Secured Creditors of Dr. Agarwal''s Eye Hospital Limited is submitted.
Others (Uncategorized) · 03 Jul 2026, 4:22 am
Secured Creditors Approve Amalgamation Scheme Dr. Agarwal's Eye Hospital Limited announced that the scheme of amalgamation with Dr. Agarwal's Health Care Limited was approved by its secured creditors. At the NCLT-convened meeting on 2nd Jul'26, the resolution passed with 100% of votes in favour, representing a total value of INR 85,77,34,403. This approval is a key step in completing the proposed merger between the transferor company (Dr. Agarwal's Eye Hospital) and the transferee company (Dr. Agarwal's Health Care). The result was determined via remote e-voting.
Summary of the proceedings of the Honble NCLT convened meeting of the secured creditors of Dr. Agarwal''s Eye Hospital Limited held on July 02, 2026, is submitted.
Others (Uncategorized) · 03 Jul 2026, 4:16 am
Dr. Agarwal's Secured Creditors Approve Amalgamation Scheme In an NCLT-convened meeting on 02 Jul'26, the sole secured creditor of Dr. Agarwal's Eye Hospital Limited approved the Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The resolution to approve the merger, which positions Dr. Agarwal's Eye Hospital as the transferor company, was passed with the requisite special majority. This marks a key procedural step in the proposed corporate consolidation. The meeting concluded at 10:45 A.M. after voting via e-voting and polling papers.
The voting results of the Hon''ble NCLT convened meeting of the Equity Shareholders of Dr. Agarwal''s Eye Hospital Limited is submitted. The resolution set out in the notice have been duly ....
Court Convened Meeting · 03 Jul 2026, 3:16 am
Shareholders Approve Amalgamation Scheme for Dr. Agarwal's Eye Hospital On 02 Jul'26, shareholders of Dr. Agarwal's Eye Hospital Limited approved the Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The special resolution passed with an overwhelming majority, receiving 89.87% of total votes in favour. Promoter group voting was unanimously in favour (100%). Public institutional and non-institutional shareholders also approved the resolution, with 51.90% of their votes cast in favour and 48.10% against. Overall, 92.06% of total outstanding shares participated in the vote, indicating strong shareholder engagement.
Summary of proceedings of the NCLT convened meetings of the Equity Shareholders of Dr. Agarwal''s Eye Hospital Limited held on July 02, 2026 is submitted.
Court Convened Meeting · 03 Jul 2026, 1:52 am
Dr. Agarwal's Eye Hospital Shareholders Meet to Approve Amalgamation Scheme Equity shareholders of Dr. Agarwal's Eye Hospital Limited met on Jul 02, '26, as convened by the NCLT, to approve the Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The resolution to approve the merger of the transferor company (Dr. Agarwal's Eye Hospital) into the transferee company (Dr. Agarwal's Health Care) required a special majority. The meeting, which met the requisite quorum, proceeded with voting via e-voting and polling papers. The outcome of the shareholder vote is pending the Scrutinizer's consolidated report.
Re-affirmation and withdrawal of Credit Rating by CRISIL Ratings Limited with respect to the debt facilities availed by the Company is submitted.
Others (Uncategorized) · 17 Jun 2026, 1:28 am
CRISIL Reaffirms and Withdraws Dr. Agarwal's 'AA-/Stable' Debt Rating CRISIL Ratings has re-affirmed its 'Crisil AA-/Stable' rating for Dr. Agarwal's Eye Hospital's debt facilities totaling ₹130 crore and subsequently withdrawn it. The withdrawal, effective Jun 15, '26, was initiated at the company's request and supported by a no-objection certificate from lenders. The company's debt facilities, including term loans of ₹126 crore and cash credit of ₹4 crore from Axis Bank, will continue to be rated by ICRA Limited. This move signals a consolidation of rating agencies by the company.
Letter providing direct weblink and a Static Quick Response Code to the Notice of the Equity Shareholders and Creditors dispatched by the Company, is submitted.
Others (Uncategorized) · 01 Jun 2026, 11:44 pm
Dr. Agarwal's Eye Hospital Convenes Meetings to Approve Amalgamation Dr. Agarwal's Eye Hospital (BSE: 526783) will hold NCLT-convened meetings on 2nd Jul'26 to approve the proposed Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The Equity Shareholders' meeting is scheduled for 9:00 AM, followed by the Unsecured Creditors' meeting at 11:30 AM. The cut-off date for e-voting eligibility for shareholders is 3rd Jun'26. The remote e-voting window for both shareholder and creditor meetings is from 7th Jun'26 to 1st Jul'26. Physical letters are being sent to stakeholders without registered email addresses.
Notice convening the meeting of the unsecured creditors of the Company pursuant to the order of the Hon''ble Tribunal, Chennai Bench, is submitted.
Others (Uncategorized) · 01 Jun 2026, 6:46 pm
Dr. Agarwal's Eye Hospital Announces Unsecured Creditor Meeting for Amalgamation Dr. Agarwal's Eye Hospital Ltd (AEHL) will hold a meeting for its unsecured creditors on 02 Jul'26 to approve its amalgamation with Dr. Agarwal's Health Care Ltd (AHCL). This follows a National Company Law Tribunal order dated 05 May'26. The cut-off date for voting eligibility is 31 Dec'25. A remote e-voting period is scheduled from 07 Jun'26 to 01 Jul'26. The merger aims to create operational efficiencies, unify capital allocation, and enhance shareholder value, with the transaction expected to be EPS accretive from year one.
Notice convening the meeting of the Secured Creditors of the Company pursuant to the order of the Hon''ble NCLT, Chennai Bench.
Others (Uncategorized) · 01 Jun 2026, 6:41 pm
Dr. Agarwal's Eye Hospital Schedules Secured Creditors' Meeting for Amalgamation Approval Dr. Agarwal's Eye Hospital Ltd (AEHL) will hold a National Company Law Tribunal-convened meeting of its Secured Creditors on 02 Jul'26 to approve its amalgamation with Dr. Agarwal's Health Care Ltd (AHCL). The scheme proposes a share exchange ratio where AEHL shareholders receive 23 AHCL shares for every 2 AEHL shares held. Remote e-voting is available from 07 Jun'26 to 01 Jul'26. The cut-off date for determining voting eligibility is 31 Dec'25. The amalgamation aims to enhance operational efficiencies and shareholder value.